Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden

被引:6
作者
Nugin, Hampus [1 ]
Folkvaljon, Yasin [2 ]
Damber, Jan-Erik [3 ]
Adolfsson, Jan [4 ]
Robinson, David [5 ]
Stattin, Par [6 ]
机构
[1] Falun Cent Hosp, Dept Surg, Falun, Sweden
[2] Uppsala Univ Hosp, Reg Canc Ctr Uppsala Orebro, Uppsala, Sweden
[3] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Clin Sci, Dept Urol,Sahlgrenska Acad, Gothenburg, Sweden
[4] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[5] Ryhov Hosp, Dept Urol, Jonkoping, Sweden
[6] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Prostate cancer; cancer guidelines; quality indicators; socio-economical differences; cancer registries; REGISTER; QUALITY; MEN;
D O I
10.1080/21681805.2018.1512650
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: In 2007, the Swedish National Board of Health and Welfare published the first Swedish guidelines on prostate cancer (PCa) to improve care and decrease geographical and social inequalities. The aim of this analysis was to assess how these guidelines affected PCa care. Materials and Methods: Work-up and treatment for men diagnosed with PCa between 1998 and 2014 were assessed by use of data in the Prostate Cancer data Base Sweden (PCBaSe) with information from the National Prostate Cancer Register (NPCR) and other healthcare registries and demographic databases. Results: Overall, there were modest improvements in the performance for 14 selected quality indicators, with some notable exceptions. There was a strong increase in the use of active surveillance for very low-risk PCa, up from 56% in 2009 to 92% in 2014, and use of bone imaging for high-risk PCa up from 50% in 2008 to 77% in 2014. There were large differences in work-up and treatment of PCa between healthcare providers with modest decreases over time. The differences between counties were larger than differences according to socioeconomic status with one exception: use of curative treatment for high-risk PCa was more common in men with high income, highest versus lowest tertile, OR 2.74 (95% CI, 1.85-4.06). Conclusion: The modest improvements in PCa care after the publications of national guidelines indicate that if these are to make an impact on care, feedback to each point of care on their performance as well as local quality improvement programs implementing the guidelines are needed.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 50 条
  • [1] THE PROSTATE CENTER: MULTIDISCIPLINARITY, ORGANIZATION OF DIAGNOSTIC WORK-UP AND TREATMENT OF PROSTATE CANCER
    Kulis, Tomislav
    Penezic, Luka
    Gamulin, Marija
    Mokos, Ivica
    Maric, Marjan
    Ferencak, Vladimir
    Goluza, Eleonora
    Hudolin, Tvrtko
    Kastelan, Zeljko
    ACTA CLINICA CROATICA, 2019, 58 (01) : 16 - 20
  • [2] Evaluation of Proclarix in the diagnostic work-up of prostate cancer
    Kaufmann, Basil
    Fischer, Sharon
    Athanasiou, Alcibiade
    Lautenbach, Noemie
    Wittig, Anja
    Bieri, Uwe
    Schmid, Florian A.
    von Stauffenberg, Franz
    Scherer, Thomas
    Eberli, Daniel
    Gorin, Michael A.
    Schiess, Ralph
    Poyet, Cedric
    BJUI COMPASS, 2024, 5 (02): : 297 - 303
  • [3] Value of Multiparametric MRI in the Work-up of Prostate Cancer
    Cornud, F.
    Delongchamps, N. B.
    Mozer, P.
    Beuvon, F.
    Schull, A.
    Muradyan, N.
    Peyromaure, M.
    CURRENT UROLOGY REPORTS, 2012, 13 (01) : 82 - 92
  • [4] Value of Multiparametric MRI in the Work-up of Prostate Cancer
    F. Cornud
    N. B. Delongchamps
    P. Mozer
    F. Beuvon
    A. Schull
    N. Muradyan
    M. Peyromaure
    Current Urology Reports, 2012, 13 : 82 - 92
  • [5] Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
    Cazzaniga, Walter
    Ventimiglia, Eugenio
    Alfano, Massimo
    Robinson, David
    Lissbrant, Ingela Franck
    Carlsson, Stefan
    Styrke, Johan
    Montorsi, Francesco
    Salonia, Andrea
    Stattin, Par
    FRONTIERS IN MEDICINE, 2019, 6
  • [6] The importance of MRI evaluation in the preoperative work-up of prostate cancer
    Gerst, SR
    Touijer, AK
    Guillonneau, B
    Al-Ahmadie, H
    Mehdizade, A
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (11): : 565 - 571
  • [7] Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
    Adolfsson, Jan
    Garmo, Hans
    Varenhorst, Eberhard
    Ahlgren, Goran
    Ahlstrand, Christer
    Andren, Ove
    Bill-Axelson, Anna
    Bratt, Ola
    Damber, Jan-Erik
    Hellstrom, Karin
    Hellstrom, Magnus
    Holmberg, Erik
    Holmberg, Lars
    Hugosson, Jonas
    Johansson, Jan-Erik
    Petterson, Bill
    Tornblom, Magnus
    Widmark, Anders
    Stattin, Par
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (06): : 456 - 477
  • [8] Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
    Stattin, Par
    Holmberg, Erik
    Johansson, Jan-Erik
    Holmberg, Lars
    Adolfsson, Jan
    Hugosson, Jonas
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13): : 950 - 958
  • [9] Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
    Janopaul-Naylor, James R.
    Corriher, Taylor J.
    Switchenko, Jeffrey
    Hanasoge, Sheela
    Esdaille, Ashanda
    Mahal, Brandon A.
    Filson, Christopher P.
    Patel, Sagar A.
    CANCER MEDICINE, 2023, 12 (17): : 18258 - 18268
  • [10] Geographical variation in incidence of prostate cancer in Sweden -: Survey from the National Prostate Cancer Register
    Stattin, P
    Johansson, R
    Lodnert, R
    Andrén, O
    Bill-Axelsson, A
    Bratt, O
    Damber, JE
    Hellström, M
    Hugosson, J
    Lundgren, R
    Törnblom, M
    Varenhorst, E
    Johansson, JE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (05): : 372 - 379